Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Optimizing treatment of mild to moderate ulcerative colitis: CU-forum Delphi consensus.
Gastroenterol Hepatol. 2023 Dec;46(10):784-794. doi: 10.1016/j.gastrohep.2023.01.014. Epub 2023 Feb 15.
Gastroenterol Hepatol. 2023.
PMID: 36803681
English, Spanish.
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.
Danese S, Colombel JF, Lukas M, Gisbert JP, D'Haens G, Hayee B, Panaccione R, Kim HS, Reinisch W, Tyrrell H, Oh YS, Tole S, Chai A, Chamberlain-James K, Tang MT, Schreiber S; GARDENIA Study Group.
Danese S, et al.
Lancet Gastroenterol Hepatol. 2022 Feb;7(2):118-127. doi: 10.1016/S2468-1253(21)00294-6. Epub 2021 Nov 17.
Lancet Gastroenterol Hepatol. 2022.
PMID: 34798038
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite